Teva Pharmaceutical Industries Limited Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (393)

Latest Posts

About This Stock More About This Stock
Teva Maneuvers To Match 30% Discounts For Generic Copaxone
Article By: Shock Exchange
Friday, October 13, 2017 12:09 PM EDT
Market chatter suggests Mylan is offering 25%-30% discounts on generic Copaxone, and Teva is scrambling to match the discounts. If Teva has to lower Q4 earnings guidance investors could punish the stock.
In this article: TEVA, MYL
Read
Ask Slim Market Week - Friday, Oct 06
Video By: Steve Miller
Friday, October 6, 2017 8:05 PM EDT
The stock market surged most of the week with only a slightly disappointing jobs report able to pull the market down.
In this video: DAL, JWN, LEN, M, UAL, COST, MYL, NFLX, TEVA, TWTR, GPRO
Watch
Pharma Stock Roundup: Mylan Up, Teva Down On Copaxone News, Lawmakers Question Allergan Deal
Article By: Arpita Dutt
Friday, October 6, 2017 10:31 AM EDT
While Mylan and Teva were in the news related to the FDA approval of Mylan’s generic versions of Teva’s top-selling branded drug, Copaxone, Allergan is under fire for its agreement with the Saint Regis Mohawk Tribe for Restasis.
In this article: AGN, TEVA, MYL Also: NVO, SNY, LLY, GSK
Read
Teva Punished By Mylan, Generic Copaxone
Article By: Shock Exchange
Thursday, October 5, 2017 7:54 AM EDT
TEVA fell 14% after MYL was approved for generic Copaxone. A 70% decline in Copaxone sales could be in the cards. Copaxone was 18% of Teva's Q2 revenue. The hit to Teva's EBITDA could be sizeable given rising prices for multiple sclerosis treatments.
In this article: TEVA, MYL
Read
Teva Kicks The Can Down The Road
Article By: Shock Exchange
Monday, October 2, 2017 5:18 PM EDT
Teva amended leverage covenants in certain of its credit agreements, but it does not improve the company's credit metrics. Headwinds in generics and Copaxone could send its debt deeper into junk territory. Teva is kicking the can down the road.
In this article: TEVA Also: MYL, AGN
Read

PARTNER HEADLINES

Latest Tweets for $TEVA

No tweets yet!

$TEVA

Teva Surprised On The Upside Today; Reporting Q4 Sales Of $6.5 Billion
Ayelet Wolf 2/13/2017 9:33:07 PM

A nice bounce for #Teva. Happy to see such gains after the recent turmoil, $TEVA

Teva CEO Vigodman Is Out
Donald Kaplan 2/7/2017 12:05:20 AM

#Vigodman was killing #Teva. This is good news for the stock. $TEVA!

Teva CEO Vigodman Is Out
Ayelet Wolf 2/7/2017 12:02:32 AM

Someone who was born in Israel. I agree with the author that #Teva should be looking first at who can best fill the CEO role regardless of where he or she is from. $TEVA

Teva CEO Vigodman Is Out
Alexa Graham 2/7/2017 12:01:20 AM

Thanks for breaking this big news about $TEVA! But what's a sabra?

1 to 4 of 4 comments